Heart failure with preserved ejection fraction in adults with congenital heart disease
Heart failure with preserved ejection fraction is highly prevalent among ACHD patients, regardless of ACHD severity. It is associated with an increased burden of cardiovascular risk factors and hospitalizations. Despite this, only a minority received SGLT2 inhibitors. These findings emphasize the need for increased awareness of HFpEF in the ACHD population.
Authors
- Jani Thuraiaiyah (ORCID: https://orcid.org/0000-0002-8544-5185)
- Julie Bjerre Tarp
- Jakob Raunsoe
- Søren Schoett Schmiegelow
- Annette Schophuus Jensen (ORCID: https://orcid.org/0000-0003-4170-6416)
- Rebekka Lytzen (ORCID: https://orcid.org/0009-0008-2628-4239)
- D Nerst
- L Koeber
- Troels Hoejsgaard Joergensen
- Rebecca Lykkegaard Kambskard
- Vanilla Maegaard Eriksen
- Chee Woon Lim
- Catriona Thekla King
Institutions
- University of Copenhagen (DK)
- Royal North Shore Hospital (AU)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- European Heart Journal
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1093/eurheartj/ehag017
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 30.07